EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Single cell network profiling (SCNP): mapping drug and target interactions



Single cell network profiling (SCNP): mapping drug and target interactions



Assay and Drug Development Technologies 8(3): 321-343



Measuring target coverage of small molecule inhibitors is paramount-first, for selection of molecules to progress through the drug development process and second, once a candidate drug moves to clinical testing, for guiding dose/schedule selection. Single cell network profiling (SCNP) using multiparameter flow cytometry can measure compound effects on multiple signaling cascades in a cell-type-specific manner. We applied SCNP to a panel of compounds with reported inhibitory effects on Jak/Stat signaling using a novel system where modulation of multiple signaling cascades are simultaneously measured in discrete cell subsets in whole (ie, unfractionated) blood. Jak2 vs. Jak3 selectivity as well as "off-target" effects on other cell signaling pathways were measured using a combination of cytokines that target different white blood cell subsets, namely GM-CSF (monocytes/granulocytes), IL-2 (T cells), and CD40L (B cells). The compounds were then rank-ordered by potency and selectivity against the different pathways tested. Notably, SCNP performed in whole unfractionated blood compared to fractionated peripheral blood mononuclear cells (PBMC) from the same donors revealed potency loss for all compounds, with one exception. These studies show that SCNP can be used to efficiently measure a drug candidate's potency and selectivity in a physiologically relevant environment (eg, whole blood) and that robust IC(50) are attainable from rare subpopulations (<100 cells). The ability to generate in vitro IC(50) measurements in whole blood can be used not only for the preclinical selection of lead molecules, but also to determine the target plasma concentration for clinical studies and to measure target coverage after drug administration in early phase clinical trials. Knowledge of the compound plasma concentration necessary to achieve biochemical coverage permits rational design of clinical trials based on biologically active dose vs. the traditional maximum tolerated dose (MTD) design, which is better suited for cytotoxic, nontargeted drugs.

(PDF same-day service: $19.90)

Accession: 055793362

Download citation: RISBibTeXText

PMID: 20158439

DOI: 10.1089/adt.2009.0251



Related references

Single-cell network profiling (SCNP) by flow cytometry in autoimmune disease. Autoimmunity 43(7): 550-559, 2011

Immune monitoring technology primer: Single Cell Network Profiling (SCNP). Journal for ImmunoTherapy of Cancer 3: 34-34, 2015

Quantitative measurement of alterations in DNA damage repair (DDR) pathways using single cell network profiling (SCNP). Journal of Translational Medicine 12(): 184-184, 2015

Immune system functional pathway analysis using single cell network profiling (SCNP): a novel tool in cancer immunotherapy. Methods in Molecular Biology 1102: 583-599, 2014

Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP). Plos One 5(10): E13543-E13543, 2011

Prediction of drug-target interactions and drug repositioning via network-based inference. Plos Computational Biology 8(5): E1002503-E1002503, 2012

SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning. Briefings in Bioinformatics (): -, 2016

Reverse Chemical Genetics: Comprehensive Fitness Profiling Reveals the Spectrum of Drug Target Interactions. Plos Genetics 12(9): E1006275-E1006275, 2016

Computational Prediction of DrugTarget Interactions Using Chemical, Biological, and Network Features. Molecular Informatics 33(10): 669-681, 2014

Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies. Haematologica 98(4): 626-634, 2013

Computational biology and drug discovery: From single-target to network drugs. Current Bioinformatics 1(1): 3-13, 2006

Predicting drug target interactions using meta-path-based semantic network analysis. Bmc Bioinformatics 17(): 160-160, 2016

Single-bead, single-molecule, single-cell fluorescence: technologies for drug screening and target validation. Annals of the New York Academy of Sciences 1130: 1-11, 2008

Single cell network profiling assay in bladder cancer. Cytometry. Part A 83(4): 386-395, 2013

Protein interactions: mapping interactome networks to support drug target discovery and selection. Methods in Molecular Biology 910: 279-296, 2013